Cytochromes and psychotropic drug interactions

被引：35

作者：

Taylor, D ^{[1
]}

Lader, M ^{[1
]}

机构：

[1] MAUDSLEY HOSP & INST PSYCHIAT,LONDON SE5 8AF,ENGLAND

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1996年 / 168卷 / 05期

关键词：

LIVER-MICROSOMES; FLUOXETINE; FLUVOXAMINE; METABOLISM; IMIPRAMINE; INHIBITION; ALPRAZOLAM; CLOZAPINE; MIDAZOLAM;

D O I：

10.1192/bjp.168.5.529

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：529 / 532

页数：4

共 30 条

[1]

ALDERMAN J, 1994, DESIPRAMINE PHARMACO

[2]

BARROS J, 1993, AM J PSYCHIAT, V150, P1751

[3] FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J].

BROSEN, K ;

SKJELBO, E ;

RASMUSSEN, BB ;

POULSEN, HE ;

LOFT, S .

BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1211-1214

[4]

CENTORRINO F, 1994, AM J PSYCHIAT, V151, P123

[5] THE ROLE OF INDIVIDUAL HUMAN CYTOCHROMES-P450 IN DRUG-METABOLISM AND CLINICAL-RESPONSE [J].

CHOLERTON, S ;

DALY, AK ;

IDLE, JR .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (12) :434-439

[6] THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON CYTOCHROME-P4502D6 (CYP2D6) ACTIVITY IN HUMAN LIVER-MICROSOMES [J].

CREWE, HK ;

LENNARD, MS ;

TUCKER, GT ;

WOODS, FR ;

HADDOCK, RE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :262-265

[7]

FISCHER V, 1992, J PHARMACOL EXP THER, V260, P1355

[8] INVITRO FORECASTING OF DRUGS WHICH MAY INTERFERE WITH THE BIOTRANSFORMATION OF MIDAZOLAM [J].

GASCON, MP ;

DAYER, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (06) :573-578

[9]

GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643

[10] CITALOPRAM - INTERACTION STUDIES WITH LEVOMEPROMAZINE, IMIPRAMINE, AND LITHIUM [J].

GRAM, LF ;

HANSEN, MGJ ;

SINDRUP, SH ;

BROSEN, K ;

POULSEN, JH ;

AAESJORGENSEN, T ;

OVERO, KF .

THERAPEUTIC DRUG MONITORING, 1993, 15 (01) :18-24

← 1 2 3 →